img

Global and United States Swine Mycoplasma Pneumonia Live Vaccine Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global and United States Swine Mycoplasma Pneumonia Live Vaccine Market Report & Forecast 2024-2034

Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
Market Analysis and InsightsGlobal and United States Swine Mycoplasma Pneumonia Live Vaccine Market
This report focuses on global and United States Swine Mycoplasma Pneumonia Live Vaccine market, also covers the segmentation data of other regions in regional level and county level.
The global Swine Mycoplasma Pneumonia Live Vaccine revenue was US$ 214 million in 2022 and is forecast to a readjusted size of US$ 337.1 million by 2033 with a CAGR of 6.2% during the forecast period (2023-2033).
In United States the Swine Mycoplasma Pneumonia Live Vaccine revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period (2023-2033).
The global key players of Swine Mycoplasma Pneumonia Live Vaccine include Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Santé Animale, Harbin Pharmaceutical Group, Qilu Animal Health Products, Guangdong Winsun Bio-Pharmaceutical and Jilin HeYuan Bioengineering, etc. The global five biggest players hold a share of % in 2022.
Global Swine Mycoplasma Pneumonia Live Vaccine Scope and Market Size
Swine Mycoplasma Pneumonia Live Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Swine Mycoplasma Pneumonia Live Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2033.
For United States market, this report focuses on the Swine Mycoplasma Pneumonia Live Vaccine market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Zoetis
Boehringer Ingelheim
Merck
HIPRA
Ceva Santé Animale
Harbin Pharmaceutical Group
Qilu Animal Health Products
Guangdong Winsun Bio-Pharmaceutical
Jilin HeYuan Bioengineering
Jofunhwa Biotechnology
Segment by Type
168 Strains
RM48 Strains
Other

Segment by Application


Piglets
Adult Pigs
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Swine Mycoplasma Pneumonia Live Vaccine definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Swine Mycoplasma Pneumonia Live Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Swine Mycoplasma Pneumonia Live Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Mycoplasma Pneumonia Live Vaccine sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Swine Mycoplasma Pneumonia Live Vaccine Product Introduction
1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Outlook 2018 VS 2022 VS 2033
1.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in US$ Million for the Year 2018-2033
1.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume for the Year 2018-2033
1.3 United States Swine Mycoplasma Pneumonia Live Vaccine Outlook 2018 VS 2022 VS 2033
1.3.1 United States Swine Mycoplasma Pneumonia Live Vaccine Sales in US$ Million for the Year 2018-2033
1.3.2 United States Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume for the Year 2018-2033
1.4 Swine Mycoplasma Pneumonia Live Vaccine Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4.1 The Market Share of United States Swine Mycoplasma Pneumonia Live Vaccine in Global, 2018 VS 2022 VS 2033
1.4.2 The Growth Rate of Swine Mycoplasma Pneumonia Live Vaccine Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.5 Swine Mycoplasma Pneumonia Live Vaccine Market Dynamics
1.5.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Trends
1.5.2 Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
1.5.3 Swine Mycoplasma Pneumonia Live Vaccine Market Challenges
1.5.4 Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Swine Mycoplasma Pneumonia Live Vaccine by Type
2.1 Swine Mycoplasma Pneumonia Live Vaccine Market Segment by Type
2.1.1 168 Strains
2.1.2 RM48 Strains
2.1.3 Other
2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size by Type
2.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Value, by Type (2018, 2022 & 2033)
2.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Type (2018, 2022 & 2033)
2.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2033)
2.3 United States Swine Mycoplasma Pneumonia Live Vaccine Market Size by Type
2.3.1 United States Swine Mycoplasma Pneumonia Live Vaccine Sales in Value, by Type (2018, 2022 & 2033)
2.3.2 United States Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Type (2018, 2022 & 2033)
2.3.3 United States Swine Mycoplasma Pneumonia Live Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2033)
3 Swine Mycoplasma Pneumonia Live Vaccine by Application
3.1 Swine Mycoplasma Pneumonia Live Vaccine Market Segment by Application
3.1.1 Piglets
3.1.2 Adult Pigs
3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size by Application
3.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Value, by Application (2018, 2022 & 2033)
3.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Application (2018, 2022 & 2033)
3.3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Selling Price (ASP) by Application (2018, 2022 & 2033)
3.3 United States Swine Mycoplasma Pneumonia Live Vaccine Market Size by Application
3.3.1 United States Swine Mycoplasma Pneumonia Live Vaccine Sales in Value, by Application (2018, 2022 & 2033)
3.3.2 United States Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Application (2018, 2022 & 2033)
3.3.3 United States Swine Mycoplasma Pneumonia Live Vaccine Average Selling Price (ASP) by Application (2018, 2022 & 2033)
4 Global Swine Mycoplasma Pneumonia Live Vaccine Competitor Landscape by Company
4.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size by Company
4.1.1 Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Ranked by Revenue (2022)
4.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Manufacturer (2018-2023)
4.1.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Manufacturer (2018-2023)
4.1.4 Global Swine Mycoplasma Pneumonia Live Vaccine Price by Manufacturer (2018-2023)
4.2 Global Swine Mycoplasma Pneumonia Live Vaccine Concentration Ratio (CR)
4.2.1 Swine Mycoplasma Pneumonia Live Vaccine Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine in 2022
4.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Product Offered and Application
4.5 Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Swine Mycoplasma Pneumonia Live Vaccine Market Size by Company
4.7.1 Key Players of Swine Mycoplasma Pneumonia Live Vaccine in United States, Ranked by Revenue (2022)
4.7.2 United States Swine Mycoplasma Pneumonia Live Vaccine Revenue by Players (2018-2023)
4.7.3 United States Swine Mycoplasma Pneumonia Live Vaccine Sales by Players (2018-2023)
5 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size by Region
5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size in Volume by Region (2018-2033)
5.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Region: 2018-2023
5.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume Forecast by Region (2024-2033)
5.3 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size in Value by Region (2018-2033)
5.3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Region: 2018-2023
5.3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Region: 2024-2033
6 Americas
6.1 Americas Swine Mycoplasma Pneumonia Live Vaccine Market Size YoY Growth 2018-2033
6.2 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Type (2018, 2022 & 2033)
6.3 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Application (2018, 2022 & 2033)
6.4 Americas Swine Mycoplasma Pneumonia Live Vaccine Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Country (2018, 2022 & 2033)
6.4.2 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Country (2018, 2022 & 2033)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Swine Mycoplasma Pneumonia Live Vaccine Market Size YoY Growth 2018-2033
7.2 EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Type (2018, 2022 & 2033)
7.3 EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Application (2018, 2022 & 2033)
7.4 EMEA Swine Mycoplasma Pneumonia Live Vaccine Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Country (2018, 2022 & 2033)
7.4.2 EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Country (2018, 2022 & 2033)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Swine Mycoplasma Pneumonia Live Vaccine Market Size YoY Growth 2018-2033
8.2 China Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Type (2018, 2022 & 2033)
8.3 China Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Application (2018, 2022 & 2033)
9 APAC
9.1 APAC Swine Mycoplasma Pneumonia Live Vaccine Market Size YoY Growth 2018-2033
9.2 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Type (2018, 2022 & 2033)
9.3 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume, by Application (2018, 2022 & 2033)
9.4 APAC Swine Mycoplasma Pneumonia Live Vaccine Market Facts & Figures by Region (2018, 2022 & 2033)
9.4.1 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Region (2018, 2022 & 2033)
9.4.2 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Region (2018, 2022 & 2033)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Zoetis
10.1.1 Zoetis Company Information
10.1.2 Zoetis Description and Business Overview
10.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.1.5 Zoetis Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Description and Business Overview
10.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Description and Business Overview
10.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.3.5 Merck Recent Development
10.4 HIPRA
10.4.1 HIPRA Company Information
10.4.2 HIPRA Description and Business Overview
10.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.4.5 HIPRA Recent Development
10.5 Ceva Santé Animale
10.5.1 Ceva Santé Animale Company Information
10.5.2 Ceva Santé Animale Description and Business Overview
10.5.3 Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.5.5 Ceva Santé Animale Recent Development
10.6 Harbin Pharmaceutical Group
10.6.1 Harbin Pharmaceutical Group Company Information
10.6.2 Harbin Pharmaceutical Group Description and Business Overview
10.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.6.5 Harbin Pharmaceutical Group Recent Development
10.7 Qilu Animal Health Products
10.7.1 Qilu Animal Health Products Company Information
10.7.2 Qilu Animal Health Products Description and Business Overview
10.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.7.5 Qilu Animal Health Products Recent Development
10.8 Guangdong Winsun Bio-Pharmaceutical
10.8.1 Guangdong Winsun Bio-Pharmaceutical Company Information
10.8.2 Guangdong Winsun Bio-Pharmaceutical Description and Business Overview
10.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.8.5 Guangdong Winsun Bio-Pharmaceutical Recent Development
10.9 Jilin HeYuan Bioengineering
10.9.1 Jilin HeYuan Bioengineering Company Information
10.9.2 Jilin HeYuan Bioengineering Description and Business Overview
10.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.9.5 Jilin HeYuan Bioengineering Recent Development
10.10 Jofunhwa Biotechnology
10.10.1 Jofunhwa Biotechnology Company Information
10.10.2 Jofunhwa Biotechnology Description and Business Overview
10.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Products Offered
10.10.5 Jofunhwa Biotechnology Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Chain Analysis
11.2 Swine Mycoplasma Pneumonia Live Vaccine Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Swine Mycoplasma Pneumonia Live Vaccine Production Mode & Process
11.4 Swine Mycoplasma Pneumonia Live Vaccine Sales and Marketing
11.4.1 Swine Mycoplasma Pneumonia Live Vaccine Sales Channels
11.4.2 Swine Mycoplasma Pneumonia Live Vaccine Distributors
11.5 Swine Mycoplasma Pneumonia Live Vaccine Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Swine Mycoplasma Pneumonia Live Vaccine CAGR in Value, United States VS Global, 2018 VS 2022 VS 2033
Table 2. Swine Mycoplasma Pneumonia Live Vaccine Market Trends
Table 3. Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
Table 4. Swine Mycoplasma Pneumonia Live Vaccine Market Challenges
Table 5. Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
Table 6. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Share by Manufacturer, 2018-2023
Table 13. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Share by Manufacturer, 2018-2023
Table 15. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Swine Mycoplasma Pneumonia Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Swine Mycoplasma Pneumonia Live Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Mycoplasma Pneumonia Live Vaccine as of 2022)
Table 18. Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Product Offered and Application
Table 20. Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Swine Mycoplasma Pneumonia Live Vaccine in United States, Ranked by Revenue (2022) & (US$ million)
Table 23. United States Swine Mycoplasma Pneumonia Live Vaccine Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Swine Mycoplasma Pneumonia Live Vaccine Revenue Share by Players, (2018-2023)
Table 25. United States Swine Mycoplasma Pneumonia Live Vaccine Sales by Players, (K Units), (2018-2023)
Table 26. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Share by Players, (2018-2023)
Table 27. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 28. Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume Forecast by Region (2024-2033) & (K Units)
Table 30. Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Forecast by Region (2024-2033) & (US$ Million)
Table 32. Americas Swine Mycoplasma Pneumonia Live Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Country (2024-2033) & (US$ Million)
Table 35. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Country (2024-2033) & (K Units)
Table 37. EMEA Swine Mycoplasma Pneumonia Live Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Country (2024-2033) & (US$ Million)
Table 40. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Country (2024-2033) & (K Units)
Table 42. APAC Swine Mycoplasma Pneumonia Live Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Country (2024-2033) & (US$ Million)
Table 45. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume by Country (2024-2033) & (K Units)
Table 47. Zoetis Company Information
Table 48. Zoetis Description and Business Overview
Table 49. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product
Table 51. Zoetis Recent Development
Table 52. Boehringer Ingelheim Company Information
Table 53. Boehringer Ingelheim Description and Business Overview
Table 54. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product
Table 56. Boehringer Ingelheim Recent Development
Table 57. Merck Company Information
Table 58. Merck Description and Business Overview
Table 59. Merck Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Merck Swine Mycoplasma Pneumonia Live Vaccine Product
Table 61. Merck Recent Development
Table 62. HIPRA Company Information
Table 63. HIPRA Description and Business Overview
Table 64. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product
Table 66. HIPRA Recent Development
Table 67. Ceva Santé Animale Company Information
Table 68. Ceva Santé Animale Description and Business Overview
Table 69. Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Product
Table 71. Ceva Santé Animale Recent Development
Table 72. Harbin Pharmaceutical Group Company Information
Table 73. Harbin Pharmaceutical Group Description and Business Overview
Table 74. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product
Table 76. Harbin Pharmaceutical Group Recent Development
Table 77. Qilu Animal Health Products Company Information
Table 78. Qilu Animal Health Products Description and Business Overview
Table 79. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product
Table 81. Qilu Animal Health Products Recent Development
Table 82. Guangdong Winsun Bio-Pharmaceutical Company Information
Table 83. Guangdong Winsun Bio-Pharmaceutical Description and Business Overview
Table 84. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product
Table 86. Guangdong Winsun Bio-Pharmaceutical Recent Development
Table 87. Jilin HeYuan Bioengineering Company Information
Table 88. Jilin HeYuan Bioengineering Description and Business Overview
Table 89. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product
Table 91. Jilin HeYuan Bioengineering Recent Development
Table 92. Jofunhwa Biotechnology Company Information
Table 93. Jofunhwa Biotechnology Description and Business Overview
Table 94. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product
Table 96. Jofunhwa Biotechnology Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Swine Mycoplasma Pneumonia Live Vaccine Customers List
Table 100. Swine Mycoplasma Pneumonia Live Vaccine Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Mycoplasma Pneumonia Live Vaccine Product Picture
Figure 2. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size 2018-2033 (US$ Million)
Figure 4. Global Swine Mycoplasma Pneumonia Live Vaccine Sales 2018-2033 (K Units)
Figure 5. United States Swine Mycoplasma Pneumonia Live Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 6. United States Swine Mycoplasma Pneumonia Live Vaccine Market Size 2018-2033 (US$ Million)
Figure 7. United States Swine Mycoplasma Pneumonia Live Vaccine Sales 2018-2033 (K Units)
Figure 8. United States Swine Mycoplasma Pneumonia Live Vaccine Market Share in Global, in Value (US$ Million) 2018-2033
Figure 9. United States Swine Mycoplasma Pneumonia Live Vaccine Market Share in Global, in Volume (K Units) 2018-2033
Figure 10. Swine Mycoplasma Pneumonia Live Vaccine Report Years Considered
Figure 11. Product Picture of 168 Strains
Figure 12. Product Picture of RM48 Strains
Figure 13. Product Picture of Other
Figure 14. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Type in 2022 & 2033
Figure 15. Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Type (2018-2033) & (US$ Million)
Figure 16. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Type (2018-2033)
Figure 17. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2018-2033) & (K Units)
Figure 18. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2018-2033)
Figure 19. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2018-2033) & (US$/Unit)
Figure 20. United States Swine Mycoplasma Pneumonia Live Vaccine Market Share by Type in 2022 & 2033
Figure 21. United States Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Type (2018-2033) & (US$ Million)
Figure 22. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Type (2018-2033)
Figure 23. United States Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2018-2033) & (K Units)
Figure 24. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2018-2033)
Figure 25. United States Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2018-2033) & (US$/Unit)
Figure 26. Product Picture of Piglets
Figure 27. Product Picture of Adult Pigs
Figure 28. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Application in 2022 & 2033
Figure 29. Global Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Application (2018-2033) & (US$ Million)
Figure 30. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Application (2018-2033)
Figure 31. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2018-2033) & (K Units)
Figure 32. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2018-2033)
Figure 33. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Application (2018-2033) & (US$/Unit)
Figure 34. United States Swine Mycoplasma Pneumonia Live Vaccine Market Share by Application in 2022 & 2033
Figure 35. United States Swine Mycoplasma Pneumonia Live Vaccine Sales in Value by Application (2018-2033) & (US$ Million)
Figure 36. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Application (2018-2033)
Figure 37. United States Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2018-2033) & (K Units)
Figure 38. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2018-2033)
Figure 39. United States Swine Mycoplasma Pneumonia Live Vaccine Price by Application (2018-2033) & (US$/Unit)
Figure 40. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume Growth Rate 2018-2033 (K Units)
Figure 41. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate 2018-2033 (US$ Million)
Figure 42. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2018-2033) & (K Units)
Figure 43. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2018-2033)
Figure 44. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2018-2033) & (K Units)
Figure 45. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2018-2033)
Figure 46. United States Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 47. Canada Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 48. Mexico Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 49. Brazil Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 50. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume Growth Rate 2018-2033 (K Units)
Figure 51. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate 2018-2033 (US$ Million)
Figure 52. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2018-2033) & (K Units)
Figure 53. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2018-2033)
Figure 54. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2018-2033) & (K Units)
Figure 55. EMEA Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2018-2033)
Figure 56. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 57. Middle East Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 58. Africa Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 59. China Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume Growth Rate 2018-2033 (K Units)
Figure 60. China Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate 2018-2033 (US$ Million)
Figure 61. China Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2018-2033) & (K Units)
Figure 62. China Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2018-2033)
Figure 63. China Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2018-2033) & (K Units)
Figure 64. China Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2018-2033)
Figure 65. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Volume Growth Rate 2018-2033 (K Units)
Figure 66. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate 2018-2033 (US$ Million)
Figure 67. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2018-2033) & (K Units)
Figure 68. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2018-2033)
Figure 69. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2018-2033) & (K Units)
Figure 70. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2018-2033)
Figure 71. Japan Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 72. South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 73. China Taiwan Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 74. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 75. India Swine Mycoplasma Pneumonia Live Vaccine Sales in Value Growth Rate (2018-2033) & (US$ Million)
Figure 76. Swine Mycoplasma Pneumonia Live Vaccine Value Chain
Figure 77. Swine Mycoplasma Pneumonia Live Vaccine Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed